Bradley J. Monk, Bradley Corr, Lin Mei, Aman Opneja, Vishal Patel, Ivy Altomare, Abdennour Ferhat, Soham D. Puvvada, Heide A. Stirnadel-Farrant, James Schmidt, Kristen Sarlo, Tian Zhang, Kathryn E. Beckermann. "A pragmatic, hybrid observational study evaluating the effectiveness of trastuzumab deruxtecan (T-DXd) in patients with human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) 3+ solid tumors: DESTINY-PanTumor04.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps11202